Aderbasib (INCB007839) is a potent, orally active and target specific low nanomolar hydroxamate-based inhibitor of ADAM10 and ADAM17. Aderbasib exhibits robust antineoplastic activity and can be used for cancer research, including diffuse large B-cell non-Hodgkin lymphoma, HER2+ breast cancer, gliomas, et al[1].
Molecular Weight:
416.47
Purity:
99.44
CAS Number:
[791828-58-5]
Formula:
C21H28N4O5
Target:
MMP
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted